
Photo: Stephen Andrews via Pexels
For a generation of nurses the rule was simple: a peripheral IV came out on day three, or day four at the latest, whether it was working or not. The re-site was scheduled like a dressing change, charted like one and audited like one. A nurse who left a good line in on day five was, on many units, out of policy.
That rule has largely gone, and the way it went is a case study in how clinical standards actually change: slowly, through a regulator declining to decide, a large trial, a systematic review, and professional standards that moved first. The replacement phrase, clinically indicated, sounds like a loosening. As assessed in a competency program, it is the opposite.
This article is about that history and about what clinically indicated means when an educator is watching you. It is not a procedure. Site assessment, documentation and removal are taught and validated against your facility's protocol, and this piece will say repeatedly where that protocol governs.
The anchor document is the CDC's Guidelines for the Prevention of Intravascular Catheter-Related Infections, published in 2011 by O'Grady and colleagues with the Healthcare Infection Control Practices Advisory Committee. Its section on replacing peripheral and midline catheters contains four lines. First: there is no need to replace peripheral catheters more frequently than every 72 to 96 hours to reduce the risk of infection and phlebitis in adults, a Category IB recommendation. Second: no recommendation is made regarding replacement of peripheral catheters in adults only when clinically indicated, recorded as an unresolved issue.
The third and fourth lines are usually forgotten: replace peripheral catheters in children only when clinically indicated (Category IB), and replace midline catheters only when there is a specific indication (Category II). Elsewhere the guideline directs that a peripheral venous catheter is removed if the patient develops signs of phlebitis, infection or a malfunctioning catheter, also Category IB.
Read carefully, the 2011 text never required a scheduled re-site. It set an upper bound on how often a catheter needed replacing and declined to rule on whether adults should be managed on clinical indication alone. The guideline remains the CDC's posted guidance, with a page date of February 2024, and has not been superseded. That matters more than it did, because HICPAC, the committee that would have revised it, was terminated by the Department of Health and Human Services in 2025, as Healio reported that May.
The evidence arrived mainly from Australia. In 2012 Rickard and colleagues published in The Lancet a multicenter randomized equivalence trial of 3,283 adults across three Queensland hospitals. Phlebitis occurred in 7% of patients in each arm, 114 of 1,593 against 114 of 1,690, an absolute difference of 0.41% inside the trial's prespecified 3% equivalence margin. Catheters in the clinically indicated arm stayed in longer, a mean of 99 hours against 70 for those still in place on day three.
The Cochrane review that pools this evidence, by Webster, Osborne, Rickard and Marsh, was last updated in January 2019 and includes nine randomized trials with 7,412 participants. There was no clear difference in catheter-related bloodstream infection (low-certainty evidence), thrombophlebitis (moderate certainty), all-cause bloodstream infection or mortality. Routine replacement probably reduces infiltration and probably reduces catheter failure from occlusion, both moderate certainty. Clinically indicated removal probably reduces device-related cost, by about 7 Australian dollars per device in the trial settings.
The authors' conclusion was measured: the newer trials found no evidence to support changing catheters every 72 to 96 hours, organizations could consider replacing catheters only when clinically indicated, and insertion sites should be inspected routinely. A 2026 cluster-randomized crossover trial from a Seoul teaching hospital, by Kang and colleagues in Healthcare, reached the same place: phlebitis in 12.6% of the clinically indicated group and 11.7% of the routine group, non-inferior within a 5% margin.
What the evidence does and does not say. Clinically indicated removal did not raise infection or phlebitis rates in the trials, and it saved cost and insertions. It did not make dwell time irrelevant: in the Cochrane pooling, routine replacement probably meant fewer infiltrations and occlusions. The trade is accepted because those are visible, assessable events, and the nurse at the bedside is the safeguard.
Printable study guide
Get the printable Peripheral IV Maintenance study guide
A printable study guide from Wahero Health Institute to the basic skills of peripheral IV maintenance: the site assessment, care and documentation that clinically indicated practice depends on. For skills lab and check-off revision; it does not replace your facility's protocol.
Peripheral IV Maintenance, $12.99
Pay by Cash App, PayPal or Zelle at checkout; the download link is emailed once the payment is confirmed, usually the same day. Study material only: it does not replace the Board's requirements, your employer's policies or the judgment of a licensed clinician.
Professional standards did not wait for the CDC. The Infusion Nurses Society's Infusion Therapy Standards of Practice, now in a ninth edition published as a supplement to the Journal of Infusion Nursing in January 2024, takes the clinically indicated position: a short peripheral catheter is removed when a clinical reason is identified rather than on a schedule. As Kang and colleagues summarize the INS position, those reasons include phlebitis, infiltration, occlusion, suspected infection, patient discomfort and completion of therapy. The edition your facility has adopted is the one your policy quotes.
Two other things are worth knowing. The ninth edition makes Aseptic Non Touch Technique the INS standard for aseptic practice, which shapes how every access of the line is assessed. And INS publishes the phlebitis and infiltration scales most US facilities use for grading, covered in our article on IV infiltration and extravasation standards; a grade on those scales is the usual documented form of a clinical indication. Our printable Peripheral IV Maintenance study guide is built around the same maintenance skills.
Under a scheduled re-site, the competency was mostly insertion. Under clinical indication, the competency moves to the catheter that is already in, and that is the part a validation program now probes hardest. An assessor wants to see four things.
First, that you treat the site as an assessment, not a glance: what you look for, in what order, and what you compare it with. The Cochrane authors' closing recommendation was simply that insertion sites be inspected routinely; your protocol sets how often and how it is recorded. Second, that you can grade what you find on the scale your facility uses and say which grade is an indication for removal under its policy. Third, that the catheter's purpose is reviewed: a line no longer in the plan of care is, in the INS framing, indicated for removal because its therapy is complete, the same logic we set out for urinary catheter competency.
Fourth, documentation. Clinically indicated practice only works if the next shift can see when the line went in, what the site looked like at each assessment, and what the plan is. An undocumented assessment is invisible at handover, and an auditor reads its absence as an assessment that did not happen. The insertion skill itself, which we describe in what IV insertion competency really takes, becomes rarer under this model.
The sentence assessors listen for. Not "the policy is four days" or "we leave them in until they fail", but: "this site is at this grade on our scale, which under our protocol means this, and here is where I documented it". The competency is the judgment, stated out loud, against a named local standard.
With trials, a Cochrane review and professional standards all pointing the same way, nurses ask why their hospital still has a fixed interval in its policy. The CDC's posted guidance still carries the 72 to 96 hour upper bound and an unresolved issue for adults, and an infection prevention committee is entitled to prefer the federal text. The Cochrane pooling found a probable increase in infiltration and occlusion under clinical indication, and a facility with weak assessment or documentation compliance may reasonably decide it is not ready to rely on them.
Whatever the policy says, it is the standard you are assessed against. In Texas, the Board of Nursing's Rule 217.11 requires every nurse to know and conform to the Nursing Practice Act and the Board's rules and to implement measures that promote a safe environment for patients; a facility's vascular access policy is one of those measures, and a nurse who removes or retains a line against it has a conversation ahead.
Educational use. This article is learning material for nurses and nursing students. It is not clinical advice, and it does not replace your employer's policies, your facility's protocols, or the judgement of a licensed clinician. Always follow the standards and procedures in force where you practise.
Does the CDC say peripheral IVs must be changed every 72 to 96 hours? No. The 2011 CDC guideline says there is no need to replace peripheral catheters more frequently than every 72 to 96 hours in adults, which is an upper bound on how often replacement is needed, not a requirement to replace on that schedule. On replacing adult catheters only when clinically indicated, the guideline makes no recommendation and records the question as an unresolved issue. For children it says to replace only when clinically indicated.
What does the Cochrane evidence actually show? The 2019 update by Webster, Osborne, Rickard and Marsh pooled nine trials with 7,412 participants and found no clear difference in catheter-related bloodstream infection, thrombophlebitis, all-cause bloodstream infection or mortality between clinically indicated and routine replacement. Routine replacement probably reduces infiltration and occlusion, and clinically indicated removal probably reduces cost. The authors suggested organizations consider replacing catheters only when clinically indicated and inspect sites routinely.
My hospital still re-sites on a schedule. Is that wrong? It is a permissible reading of the CDC's posted guidance, which still carries the 72 to 96 hour figure and leaves the adult question unresolved. The Infusion Nurses Society standards and the trial evidence point to clinical indication, so the policy may be conservative, but it is the standard you are assessed against. Raise the evidence through your education or infection prevention committee rather than departing from policy at the bedside.
Does this article tell me how to assess an IV site or when to remove a catheter? No. It describes what the standards say and what an assessor looks for. The assessment sequence, the grading scale, the frequency of checks and the removal criteria are set by your facility's protocol and taught under supervision, and this article points you to that protocol throughout.
Wahero Health Institute trains and validates peripheral IV insertion and maintenance on site for Texas facilities, against each organization's own policy and grading scale, with the daily review of the line built into the check-off.
Educational content only
This material is published by Wahero Health Institute for professional education and is not individual medical advice, a care protocol, or a substitute for clinical judgment. Always follow your facility's policies, your state's nurse practice act, and your own scope of practice, and confirm medication doses against a current authoritative reference before administration. See our Terms of Use.